Clinical Trial Update: Memantine for Agitation and Aggression in Severe Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining memantine for agitation and aggression in severe Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED